Abstract

Numerous clinical observations show that the human genetic background plays an important role in predisposition to many diseases. Objective: to investigate a possible relationship of the polymorphisms in 19 A/G leptin (LEP) gene, in the interleukin (IL)-1 receptor antagonist (IL-1RA) gene VNTR (variable number of tandem repeats), and in the -174G/C IL-6 gene to the risk of developing the clinical phenotypes of panniculitis (PN), clinical and laboratory parameters. Subjects and methods. The study enrolled 54 patients (48 women and 6 men) aged 15 to 76 years with a documented diagnosis of PN who had been treated at the V.A. Nasonova Research Institute of Rheumatology. Group 1 of 46 patients with erythema nodosum (EN) and Group 2 of 8 with Weber-Christian panniculitis (WCP) were formed for genetic study. The genotyping data on 197 healthy unrelated individuals were used as a control. Clinical and laboratory information was available from 39 patients for genotyping 19A/G LEP gene polymorphism, that from 43 patients for -174G/C IL-6 gene polymorphism, and that from 46 patients for IL-1RA polymorphism. Genotyping was performed by a polymerase chain reaction-restriction fragment length polymorphism (PCRRFLP) analysis. Results and discussion. The frequencies of the LEP 19 GG genotype and the LEP G allele in patients with EN and WCP were significantly higher than those in the controls (48.7 and 18.2%, p = 0.0004; 50.0 and 18.2%, p = 0.053; and 70.5 and 45.4%, p = 0.0002, respectively). The frequencies of the A1A1 genotype and A1 allele of IL-1RA gene VNTR polymorphism in EN group were significantly higher than those in the controls (67.4 and 44.2%, p=0.011; 80.4 and 61.6%, p = 0.002, respectively). The frequency of IL-6 -174GC polymorphism was also higher in the EN group than that in the controls (58.1 and 34.7%, p = 0.008). The -174G/C polymorphism showed a significant association with the site of erythema (p = 0.028). In patients with a single lesion of erythema on the body, the frequency of the -174 GC genotype was significantly higher than that in those with multiple foci of erythema (72.0 and 31.2%, respectively; p = 0.025). In the WCP group, analysis of variance showed an association of IL-1RA gene VNTR polymorphism with the intensity of pain, assessed by the visual analogue scale. The carriers of the A1A1 genotype had more severe pain than those of the A1A2 genotype (83.3±11.5 and 20.0±18.2 mm, respectively; p = 0.008). Conclusion. The findings suggest that genetic testing can be used to predict the clinical course of PN.

Highlights

  • Numerous clinical observations show that the human genetic background plays an important role in predisposition to many diseases

  • Clinical and laboratory information was available from 39 patients for genotyping 19A/G LEP gene polymorphism, that from 43 patients for -174G/C IL-6 gene polymorphism, and that from 46 patients for IL-1RA polymorphism

  • The frequency of IL-6 -174GC polymorphism was higher in the erythema nodosum (EN) group than that in the controls (58.1 and 34.7%, p = 0.008)

Read more

Summary

Introduction

Numerous clinical observations show that the human genetic background plays an important role in predisposition to many diseases. The frequencies of the A1A1 genotype and A1 allele of IL-1RA gene VNTR polymorphism in EN group were significantly higher than those in the controls (67.4 and 44.2%, p=0.011; 80.4 and 61.6%, p = 0.002, respectively). Длительность заболевания у пациентов с ПВК была достоверно выше по сравнению с группой УЭ (р=0,0003). СОЭ в группе пациентов с ПВК была значимо выше, чем у больных УЭ (р=0,005).

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.